In esophageal cancer, NAT10 enhances the abundance of ac4 C-modified tRNAs and further enhances the translation efficiencies of EGFR [103], which is a member of receptor tyrosine kinase family and is activated by various ligands to mediate various cellular activities to promote cancer progression. Here, NAT10 is linked to cancer.